niflumic acid has been researched along with Asthma in 8 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Excerpt | Relevance | Reference |
---|---|---|
"The effects of niflumic acid (NA), a relatively specific blocker of calcium-activated chloride channel (CLCA), on goblet cell hyperplasia, eosinophil accumulation, and airway hyperresponsiveness were evaluated after IL-13 instillation into the airways." | 7.73 | Niflumic acid suppresses interleukin-13-induced asthma phenotypes. ( Aizawa, H; Fukuyama, S; Inoue, H; Matsumoto, K; Matsumoto, T; Matsumura, M; Nakanishi, Y; Nakano, T; Tsuda, M, 2006) |
"To evaluate the inhibiting effect of niflumic acid (NFA), an inhibitor of calcium-activated chloride channel (ClCa) on airway epithelium, on the airway hyperresponsiveness in asthmatic mice." | 7.72 | [The inhibiting effect of niflumic acid on airway hyperresponsiveness in asthmatic mice]. ( Cheng, JH; Gao, F; Li, Y; Qi, HW; Song, LQ; Zhang, LN, 2004) |
"The effects of niflumic acid (NA), a relatively specific blocker of calcium-activated chloride channel (CLCA), on goblet cell hyperplasia, eosinophil accumulation, and airway hyperresponsiveness were evaluated after IL-13 instillation into the airways." | 3.73 | Niflumic acid suppresses interleukin-13-induced asthma phenotypes. ( Aizawa, H; Fukuyama, S; Inoue, H; Matsumoto, K; Matsumoto, T; Matsumura, M; Nakanishi, Y; Nakano, T; Tsuda, M, 2006) |
"To evaluate the inhibiting effect of niflumic acid (NFA), an inhibitor of calcium-activated chloride channel (ClCa) on airway epithelium, on the airway hyperresponsiveness in asthmatic mice." | 3.72 | [The inhibiting effect of niflumic acid on airway hyperresponsiveness in asthmatic mice]. ( Cheng, JH; Gao, F; Li, Y; Qi, HW; Song, LQ; Zhang, LN, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rievaj, J | 1 |
Davidson, C | 1 |
Nadeem, A | 1 |
Hollenberg, M | 1 |
Duszyk, M | 1 |
Vliagoftis, H | 1 |
Kondo, M | 1 |
Nakata, J | 1 |
Arai, N | 1 |
Izumo, T | 1 |
Tagaya, E | 1 |
Takeyama, K | 1 |
Tamaoki, J | 1 |
Nagai, A | 1 |
Song, LQ | 1 |
Li, Y | 1 |
Zhang, LN | 1 |
Gao, F | 1 |
Cheng, JH | 1 |
Qi, HW | 1 |
McNamara, N | 1 |
Gallup, M | 1 |
Khong, A | 1 |
Sucher, A | 1 |
Maltseva, I | 1 |
Fahy, J | 1 |
Basbaum, C | 1 |
Nakano, T | 1 |
Inoue, H | 1 |
Fukuyama, S | 1 |
Matsumoto, K | 1 |
Matsumura, M | 1 |
Tsuda, M | 1 |
Matsumoto, T | 1 |
Aizawa, H | 1 |
Nakanishi, Y | 1 |
Erle, DJ | 1 |
Zhen, G | 1 |
Melton, L | 1 |
Leynadier, F | 1 |
Perrault, M | 1 |
8 other studies available for niflumic acid and Asthma
Article | Year |
---|---|
Allergic sensitization enhances anion current responsiveness of murine trachea to PAR-2 activation.
Topics: Amiloride; Animals; Asthma; Benzoates; Bestrophins; Chloride Channels; Eye Proteins; Hypersensitivit | 2012 |
Niflumic acid inhibits goblet cell degranulation in a guinea pig asthma model.
Topics: Animals; Asthma; Bronchial Provocation Tests; Cell Degranulation; Disease Models, Animal; Goblet Cel | 2012 |
[The inhibiting effect of niflumic acid on airway hyperresponsiveness in asthmatic mice].
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Endothelin-1; In Vitro Tec | 2004 |
Adenosine up-regulation of the mucin gene, MUC2, in asthma.
Topics: Adenosine; Asthma; ErbB Receptors; Humans; Ion Channels; Mucin-2; Mucins; Niflumic Acid; Phosphoryla | 2004 |
Niflumic acid suppresses interleukin-13-induced asthma phenotypes.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Chloride Channels; Eosinophils; Goblet Cells; Hyperpl | 2006 |
The asthma channel? Stay tuned . . .
Topics: Animals; Asthma; Chloride Channels; Humans; Interleukin-13; Mice; Mucoproteins; Niflumic Acid; Respi | 2006 |
Does mucus hypersecretion matter in airway disease?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Female; Humans; Male; Mice; Mucus; Niflumi | 2002 |
[Anti-inflammatory agents in current therapeutics].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Arthritis, Rheumatoi | 1975 |